Relationship between lipophilicity and binding to human serum albumin of arylpropionic acid non-steroidal anti-inflammatory drugs

Journal of Pharmaceutical and Biomedical Analysis

Volumn 16, Issue 2, 1997, Pages 223-229

  Deschamps Labat, Laurence ^a   Péhourcq, Fabienne ^a   Jagou, Maryline ^a   Bannwarth, Bernard ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Arylpropionic acids; Lipophilicity; Non steroidal anti inflammatory drugs; Protein binding; Quantitative structure activity relationship

Indexed keywords

ALMINOPROFEN; ARYLPROPIONIC ACID DERIVATIVE; CARPROFEN; FENBUFEN; FENOPROFEN; FLURBIPROFEN; HUMAN SERUM ALBUMIN; IBUPROFEN; INDOPROFEN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIRPROFEN; SUPROFEN; TIAPROFENIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; EQUILIBRIUM DIALYSIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPOPHILICITY; NORMAL HUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCATCHARD PLOT; STRUCTURE ACTIVITY RELATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BINDING SITES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIALYSIS; HUMANS; MODELS, CHEMICAL; PROTEIN BINDING; SERUM ALBUMIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0343471374     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(97)00017-4     Document Type: Article

References (29)

1. F. Lapicque, N. Muller, E. Payan and N. Dubois, Clin. Pharmacokinet., 25 (1993) 115-125.
2. J. Lin, D. Cochetto and D. Duggan, Clin. Pharmacokinet., 12 (1987) 402-432.
3. K. Fehske, W. Müller and U. Wollert, Biochem. Pharmacol., 30 (1981) 687-692.
4. J.P. Tillement, G. Houin, R. Zini, S. Urien, E. Albengres, J. Barré, M. Lecomte, P. D'Athis and B. Sebille, Adv. Drug Res., 13 (1984) 59-94.
5. M. Rahman, K. Yamasaki, Y. Shin, C. Lin and M. Otagiri, Biol. Pharm. Bull., 16 (1993) 1169-1174.
6. M. Làznicek and A. Làznickovà, J. Pharm. Biomed. Anal., 13 (1995) 823-828.
7. F. Péhourcq, A. Radouane, L. Labat and B. Bannwarth, Pharm. Res., 12 (1995) 1535-1538.
8. C. Altomare, S. Cellamare, A. Carotti and M. Ferappi, Il Farmaco, 49 (1994) 393-401.
9. J. Sabatka, D. Minick, T. Shumaker, G. Hodgson and D. Brent, J. Chromatogr., 384 (1987) 349-356.
10. F. Demotes-Mainard, J. Thomas, J.J. Bosc, G. Devaux and C. Jarry, J. Liq. Chromatogr., 16 (1993) 767-776.
11. H. Kurz and B. Fichtl, Drug Metab. Rev., 14 (1983) 467-510.
12. F. Péhourcq, F. Lagrange, L. Labat and B. Bannwarth, J. Liq. Chromatogr., 18 (1995) 3969-3979.
13. J. Vallner, J. Perrin and S. Wold, J. Pharm. Sci., 65 (1976) 1182-1187.
14. K. Giacomini, A. Abang and T. Blaschke, Br. J. Clin. Pharmacol., 14 (1982) 752-754.
15. J. Seydel and K. Schaper, Pharmacol. Ther., 15 (1982) 131-182.
16. G. Wilkinson, Drug Metab. Rev., 14 (1983) 427-465.
17. R. Kaliszan, J. Chromatogr., 220 (1981) 71-83.
18. K. Valko, J. Liq. Chromatogr., 10 (1987) 1663-1686.
19. S. Rahim and A.F Aubry, J. Pharm. Sci., 84 (1995) 949-952.
20. J. Whitlam, M. Crooks, K. Brown and P. Padersen, Biochem. Pharmacol., 28 (1978) 675-678.
21. N. Dubois, F. Lapicque, M. Abiteboul and P. Netter, Chirality, 5 (1993) 126-134.
22. J. Oravcova, V. Mlynarik, S. Bystricky, L. Soltes, P. Szalay, L. Bohacik and T. Trnovec, Chirality, 3 (1991) 412-417.
23. G. Sudlow, D. Birkett and D. Wade, Mol. Pharmacol., 11 (1975) 824-832.
24. G. Sudlow, D. Birkett and D. Wade, Mol. Pharmacol., 12 (1976) 1052-1061.
25. M. Otagiri, K. Masuda, T. Imai, Y. Imamura and M. Yamasaki, Biochem. Pharmacol., 38 (1989) 1-7.
26. M. Rahman, T. Maruyama, T. Okada, K. Yamasaki and M. Otagiri, Biochem. Pharmacol., 46 (1993) 1721-1731.
27. M. Rahman, T. Maruyama, T. Okada, T. Imai and M. Otagiri, Biochem. Pharmacol., 46 (1993) 1733-1740.
28. T. Maruyama, C. Lin, K. Yamasaki, T. Miyoshi, T. Imai, M. Yamasaki and M. Otagiri, Biochem. Pharmacol., 45 (1993) 1017-1026.
29. U. Kragh-Hansen, Pharmacol. Rev., 33 (1981) 17-53.